secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2024-12-26T23:59:59+00:00
Accession:  0001213900-24-112685
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma rescinds Dec 12 securities purchase agreement; deal void ab initio
-------------------------------------------------------------------------------

- On Dec 23, 2024, company and an unnamed investor agreed to rescind the Dec 12 securities purchase agreement.
- The rescission renders the agreement void from the beginning, as disclosed in prior 8-K filed Dec 13, 2024.
- No details on investor or financial impact provided; agreement termination may affect expected capital infusion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024112685/0001213900-24-112685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024112685/ea0226033-8k_china.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-112685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer